DDInter1323 DDInter1243
Acromegaly is a disorder caused by excess growth hormone (GH), increasing the growth of body tissues and causing metabolic dysfunction. In most cases, it results from an anterior pituitary growth hormone-releasing tumor. Typically, the feet, hands, and face grow abnormally large; organomegaly and insulin resistance may also occur. Acromegaly is a life-threatening disease requiring life-long management. Octreotide is a long-acting drug with pharmacologic activities that mimic those of the natural hormone, somatostatin, which inhibits the secretion of growth hormone. Additionally, it is used for the treatment of acromegaly and symptoms arising from various tumors, including carcinoid tumors and vasoactive intestinal tumors (VIPomas). In the past, octreotide has been administered solely by injection. On June 26, 2020, the first approved delayed-release oral somatostatin analog, Mycapssa, received FDA approval for the long term maintenance
An antiarrhythmia agent used primarily for ventricular rhythm disturbances.
Octreotide {u} (Compound) causes {v} (Side Effect) Drowsiness
Drowsiness {u} (Side Effect) is caused by {v} (Compound) Methotrimeprazine
Methotrimeprazine {u} (Compound) resembles {v} (Compound) Moricizine
Octreotide {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Miglitol
Miglitol {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Methotrimeprazine
Methotrimeprazine {u} (Compound) resembles {v} (Compound) Moricizine
Octreotide {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Pramlintide
Pramlintide {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Trifluoperazine
Trifluoperazine {u} (Compound) resembles {v} (Compound) Moricizine
Octreotide {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Glasdegib
Glasdegib {u} may lead to a major life threatening interaction when taken with {v} Thioridazine
Thioridazine {u} (Compound) resembles {v} (Compound) Moricizine
Octreotide {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Insulin lispro
Insulin lispro {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Methotrimeprazine
Methotrimeprazine {u} (Compound) resembles {v} (Compound) Moricizine
Octreotide {u} (Compound) resembles {v} (Compound) Pasireotide
Pasireotide {u} may lead to a major life threatening interaction when taken with {v} Methotrimeprazine
Methotrimeprazine {u} (Compound) resembles {v} (Compound) Moricizine
Octreotide {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Procainamide
Procainamide {u} (Compound) resembles {v} (Compound) Moclobemide
Moclobemide {u} (Compound) resembles {v} (Compound) Moricizine
Octreotide {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Procainamide
Procainamide {u} (Compound) binds {v} (Gene) SCN5A
SCN5A {u} (Gene) is bound by {v} (Compound) Moricizine
Octreotide {u} (Compound) resembles {v} (Compound) Desmopressin
Desmopressin {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Chlorpromazine
Chlorpromazine {u} (Compound) resembles {v} (Compound) Moricizine
Octreotide {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Nifedipine
Nifedipine {u} (Compound) downregulates {v} (Gene) SLC35A1
SLC35A1 {u} (Gene) is downregulated by {v} (Compound) Moricizine
Octreotide (Compound) causes Drowsiness (Side Effect) and Drowsiness (Side Effect) is caused by Methotrimeprazine (Compound) and Methotrimeprazine (Compound) resembles Moricizine (Compound)
Octreotide may cause a moderate interaction that could exacerbate diseases when taken with Miglitol and Miglitol may cause a moderate interaction that could exacerbate diseases when taken with Methotrimeprazine and Methotrimeprazine (Compound) resembles Moricizine (Compound)
Octreotide may cause a moderate interaction that could exacerbate diseases when taken with Pramlintide and Pramlintide may cause a moderate interaction that could exacerbate diseases when taken with Trifluoperazine and Trifluoperazine (Compound) resembles Moricizine (Compound)
Octreotide may cause a moderate interaction that could exacerbate diseases when taken with Glasdegib and Glasdegib may lead to a major life threatening interaction when taken with Thioridazine and Thioridazine (Compound) resembles Moricizine (Compound)
Octreotide may cause a moderate interaction that could exacerbate diseases when taken with Insulin lispro and Insulin lispro may cause a moderate interaction that could exacerbate diseases when taken with Methotrimeprazine and Methotrimeprazine (Compound) resembles Moricizine (Compound)
Octreotide (Compound) resembles Pasireotide (Compound) and Pasireotide may lead to a major life threatening interaction when taken with Methotrimeprazine and Methotrimeprazine (Compound) resembles Moricizine (Compound)
Octreotide may cause a moderate interaction that could exacerbate diseases when taken with Procainamide and Procainamide (Compound) resembles Moclobemide (Compound) and Moclobemide (Compound) resembles Moricizine (Compound)
Octreotide may cause a moderate interaction that could exacerbate diseases when taken with Procainamide and Procainamide (Compound) binds SCN5A (Gene) and SCN5A (Gene) is bound by Moricizine (Compound)
Octreotide (Compound) resembles Desmopressin (Compound) and Desmopressin may cause a moderate interaction that could exacerbate diseases when taken with Chlorpromazine and Chlorpromazine (Compound) resembles Moricizine (Compound)
Octreotide may cause a moderate interaction that could exacerbate diseases when taken with Nifedipine and Nifedipine (Compound) downregulates SLC35A1 (Gene) and SLC35A1 (Gene) is downregulated by Moricizine (Compound)